COYA vs PCG · rev $7.9M vs P/E 13, rev $12.78B
Coya Therapeutics, Inc. Common Stock (COYA) versus PG&E Corp (PCG) — a side-by-side from cached financials, not a winner call.
Coya Therapeutics, Inc. Common Stock (COYA) is a biotechnology company listed on NASDAQ.
PG&E Corp (PCG) is a utilities - regulated electric company listed on US.
Latest reported COYA revenue for 2025-12-31 was $7.9M. Net income was -$21.2M. Revenue was up 123.6% from 2024-12-31 to 2025-12-31. COYA currently screens at market cap $118.0M.
Latest reported PCG revenue for 2026-06-30 was $12.78B. Net income was $1.65B. Revenue was up 85.8% from 2026-03-31 to 2026-06-30. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
COYA currently screens at market cap $118.0M. PCG currently screens at market cap $37.68B and trailing P/E 13.3.
Not investment advice. Open the COYA and PCG stock pages for the full models.
Not investment advice.